Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 12:12:676232.
doi: 10.3389/fimmu.2021.676232. eCollection 2021.

Intestinal Microbiota-A Promising Target for Antiviral Therapy?

Mengling Yang  1 , Yang Yang  1 , Qingnan He  1 , Ping Zhu  2 , Mengqi Liu  1 , Jiahao Xu  1 , Mingyi Zhao  1
Affiliations
Review

Intestinal Microbiota-A Promising Target for Antiviral Therapy?

Mengling Yang et al. Front Immunol. .

Abstract

The intestinal microbiota is thought to be an important biological barrier against enteric pathogens. Its depletion, however, also has curative effects against some viral infections, suggesting that different components of the intestinal microbiota can play both promoting and inhibitory roles depending on the type of viral infection. The two primary mechanisms by which the microbiota facilitates or inhibits viral invasion involve participation in the innate and adaptive immune responses and direct or indirect interaction with the virus, during which the abundance and composition of the intestinal microbiota might be changed by the virus. Oral administration of probiotics, faecal microbiota transplantation (FMT), and antibiotics are major therapeutic strategies for regulating intestinal microbiota balance. However, these three methods have shown limited curative effects in clinical trials. Therefore, the intestinal microbiota might represent a new and promising supplementary antiviral therapeutic target, and more efficient and safer methods for regulating the microbiota require deeper investigation. This review summarizes the latest research on the relationship among the intestinal microbiota, anti-viral immunity and viruses and the most commonly used methods for regulating the intestinal microbiota with the goal of providing new insight into the antiviral effects of the gut microbiota.

Keywords: COVID-19; SARS-CoV-2; immunity; intestinal microbiota; virus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The possible mechanism of intestinal microbiota promoting virus infection. Intestinal microbiota can directly interact with viruses or regulate innate immunity or adaptive immunity. (A) Viruses bind with LPS or HBGA-like substances derived from intestinal microbiota. (B) Intestinal microbiota secretes protases to activate viruses. (C) Intestinal microbiota primes TLR-4 signalling to induce immunosuppressive microenvironment. (D, E) Intestinal microbiota interferes with production of antiviral antibodies or interferons.
Figure 2
Figure 2
Possible mechanisms of intestinal microbiota inhibiting virus infection. Intestinal microbiota can regulate the immune response in the gut and distal tissues and affect stability of viruses.
See this image and copyright information in PMC

References

    1. Groves HT, Cuthbertson L, James P, Moffatt MF, Cox MJ, Tregoning JS. Respiratory Disease Following Viral Lung Infection Alters the Murine Gut Microbiota. Front Immunol (2018) 9:182. 10.3389/fimmu.2018.00182 - DOI - PMC - PubMed
    1. Kumar A, Vlasova AN, Deblais L, Huang HC, Wijeratne A, Kandasamy S, et al. . Impact of Nutrition and Rotavirus Infection on the Infant Gut Microbiota in a Humanized Pig Model. BMC Gastroenterol (2018) 18(1):93. 10.1186/s12876-018-0810-2 - DOI - PMC - PubMed
    1. Denny JE, Powell WL, Schmidt NW. Local and Long-Distance Calling: Conversations Between the Gut Microbiota and Intra- and Extra-Gastrointestinal Tract Infections. Front Cell Infect Microbiol (2016) 6:41. 10.3389/fcimb.2016.00041 - DOI - PMC - PubMed
    1. Woods Acevedo MA, Erickson AK, Pfeiffer JK. The Antibiotic Neomycin Enhances Coxsackievirus Plaque Formation. mSphere (2019) 4(1):e00632-18. 10.1128/mSphere.00632-18 - DOI - PMC - PubMed
    1. Winkler ES, Thackray LB. A Long-Distance Relationship: The Commensal Gut Microbiota and Systemic Viruses. Curr Opin Virol (2019) 37:44–51. 10.1016/j.coviro.2019.05.009 - DOI - PMC - PubMed

Publication types

MeSH terms